Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor with low-dose vs regular aspirin in high-risk ACS after PCI
NCT04240834Phase 4Recruiting
- Sponsor
- Fuwai Hospital
- Start
- Feb 2021
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in acute coronary syndrome (ACS), sponsored by Fuwai Hospital. Started Feb 2021; status: recruiting.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04240834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04240834.